For GPI anchored HSPG, ccRCC patients with high expression of glypican 1, 2, 3, and 5 have lower survival rate, whereas patients with high expression of glypican 4 and 6 have higher survival rate (Table 2). This evidence concerns the gene GPC4 and nonpapillary renal cell carcinoma.